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Concentrated solutions of monoclonal antibodies have attracted considerable attention due to their
importance in pharmaceutical formulations, yet their tendency to aggregate and the resulting high
solution viscosity has posed considerable problems. It remains a very difficult task to understand
and predict the phase behavior and stability of such solutions. Here we present a systematic study
of the concentration dependence of the structural and dynamic properties of monoclonal antibodies
using a combination of different scattering methods and microrheological experiments. To interpret
these data, we use a colloid-inspired approach based on a simple patchy model, which explicitly
takes into account the anisotropic shape and the charge distribution of the molecules. Combining
theory, simulations and experiments, we are able to disentangle self-assembly and intermolecular
interactions and to quantitatively describe the concentration dependence of structural and dynamic
quantities such as the osmotic compressibility, the collective diffusion coefficient and the zero shear
viscosity over the entire range of investigated concentrations. This simple patchy model not only
allows us to consistently describe the thermodynamic and dynamic behavior of mAb solutions, but
also provides a robust estimate of the attraction between their binding sites. It will thus be an ideal
starting point for future work on antibody formulations, as it provides a quantitative assessment
of the effects of additional excipients or chemical modifications on antibody interactions, and a
prediction of their effect on solution viscosity.
Immunoglobulin gamma (IgG) constitutes the major
antibody isotype found in serum and takes part in the
immune response following an infection to the body. IgGs
contain three structured domains: two antigen binding
domains (FAB) and one so-called constant domain (FC)
arranged in a Y shape via a flexible hinge region. The
specific details of such a hinge region further classify the
IgGs into four subclasses: IgG1, IgG2, IgG3 and IgG4. In
the biopharmaceutical industry, monoclonal antibodies
(mAb) based on IgGs are a major platform for potential
drug candidates, with more than 20 mAb based drugs
available on the market and more in development [1, 2].
The popularity of these macromolecules is due to a large
flexibility in molecular recognition thanks to the variable
portions of the FAB, a long half-life time in the body,
and the possibility of humanization minimizing the risk
of immunogenicity.
In order for mAbs to become a successful pharmaceu-
tical product, not only a biological effect but also a high
chemical and formulation stability of the solutions is re-
quired. Generally, for mAb based drugs, a high concen-
tration formulation of the order of 100 g/L or more is
desirable [3, 4]. However, in many cases mAb solutions
at these concentrations exhibit dramatically altered flow
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properties, resulting in serious challenges during produc-
tion and when administering the drug.
The flow properties of protein solutions are primarily
determined by the shape of the proteins and their mutual
interactions. As the concentration increases, protein-
protein interactions become increasingly significant. De-
spite the extensive experimental and theoretical work de-
voted to protein crowding and its effects on the resulting
stability and flow properties at high protein concentra-
tion, our ability to predict for example the concentra-
tion dependence of the zero shear viscosity η0 and the
location of an arrest or glass transition is still limited [5–
14]. For antibody solutions this is a particularly difficult
problem as attractive interactions often lead to reversible
self-association between the antibody molecules [7, 9, 15–
17], making the change in solution flow properties highly
sensitive to the protein concentration [18–21].
A number of studies have made attempts to character-
ize cluster formation in mAb solutions, and to interpret
antibody solution properties through analogies with col-
loids or polymers. In particular, scattering techniques
were used to investigate protein interactions and self-
association in antibody formulations [7, 9, 22–27]. While
investigations of the self-association behavior of various
mAb formulations have frequently addressed mAb self-
association and its effect on flow properties, we are far
from having any predictive understanding and a gener-
ally accepted methodology and/or theoretical framework
to detect antibody association and model mAb interac-
tions quantitatively. A particular difficulty here is that
while the non-spherical shape and internal flexibility has
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2sometimes been addressed, interactions between proteins
are frequently treated based on spherical approximations,
and in particular the enormous effect that specific, direc-
tional interactions can have are generally not considered.
Here we present an investigation of the solution be-
havior of a monoclonal antibody varying the concentra-
tion, where we combine scattering methods and viscosity
measurements with theoretical calculations and Monte
Carlo (MC) simulations. We explicitly consider in our
model the anisotropy of both the shape and the interac-
tions of the antibody molecules. To this aim we focus on
Y-shaped molecules interacting within a simple patchy
model that is built from calculations of the electrostatic
properties of the considered mAbs. The simplicity of the
model allows for analytical treatment through Wertheim
theory [28], yielding all thermodynamic properties of the
solution and in particular the compressibility that can be
directly compared to the experimentally determined os-
motic compressibility or apparent molecular weight. In
addition, we calculate the size distribution of mAb clus-
ters using the Hyperbranched Polymer Theory (HPT)
[29], without introducing any additional free parameters.
Finally, we use MC simulations to verify the results pre-
dicted theoretically. With the explicit cluster size dis-
tribution obtained by HPT at all concentrations investi-
gated, and assuming that the dynamic solution proper-
ties (such as the apparent hydrodynamic radius Rh,app
or the relative viscosity ηr = η0/ηs, where η0 is the zero
shear viscosity and ηs is the solvent viscosity) are primar-
ily determined by excluded volume effects, we are able
to make an additional coarse-graining step in which we
model the mAb clusters as effective hard (HS) or sticky
(or adhesive) hard (SHS) spheres, for which quantitative
relationships for the concentration dependence of Rh,app
and ηr exist. We find that the measured data are indeed
well reproduced by this model, confirming that excluded
volume interactions between the assembled clusters are
at the origin of the strong increase of ηr with increas-
ing concentration. Hence, our simple model is capable
of quantitatively predicting the measured concentration-
dependence of the viscosity, solely based on static and
dynamic light scattering experiments. Our results can be
easily generalized to different types of mAbs, salt concen-
trations and temperature and may provide a crucial step
for a proper description of self-association and dynamics
of monoclonal antibodies.
EXPERIMENTAL RESULTS
We have characterized the solution behavior of a mon-
oclonal antibody (mAb) as described in Materials and
Methods. The results from these experiments are summa-
rized in Fig. 1. The static light scattering (SLS) data in
Fig. 1A show that the apparent molecular weight Mw,app
initially increases with concentration C from the known
value of the molecular weight of the mAb monomer,
i.e. M1 = 147000 g/mol, goes through a maximum at
a concentration of around C ≈ 30 mg/ml, and then
strongly decreases at higher concentrations. A similar
trend can also be seen for the apparent hydrodynamic
radius Rh,app, reported in Fig. 1B, that is obtained by
dynamic light scattering (DLS). We find that also Rh,app
initially increases from the monomer value of Rh,app ≈ 6
nm, reaches a maximum at C ≈ 150 mg/ml, and fi-
nally decreases at higher values of C. In contrast, the
reduced viscosity ηr, shown in Fig. 1C, monotonically
increases with concentration and appears to diverge for
C ≈ 200 − 300 mg/ml. Qualitatively, the concentration
dependence of the three key quantities Mw,app, Rh,app
and ηr is in agreement with a behavior where the mAb
self-assemble into aggregates with increasing concentra-
tion. While this is visible in the SLS and DLS data at low
concentrations, the influence of excluded volume effects
on the scattering data becomes more prominent at higher
concentrations and results in a decrease of the measured
values for Mw,app and Rh,app. At the same time, these in-
creasing interaction effects also result in a corresponding
increase of the zero shear viscosity of the mAb solution.
While it is straightforward to qualitatively assess the
existence of aggregation and intermolecular interactions,
a quantitative interpretation of the experimental data
would require knowledge of both the molecular weight
distribution of the resulting aggregates as well as the in-
teraction potential between antibodies. This situation is
similar to the difficulties encountered when trying to ana-
lyze scattering and rheology data of surfactant molecules
forming large polymer-like micelles [30, 31]. Crucially,
a qualitative comparison between the behavior normally
encountered for polymer-like micelles and the data shown
in Fig. 1 shows significant differences. Indeed, for
polymer-like micelles the maxima in Mw,app and Rh,app
are directly linked to the overlap concentration C∗ that
marks the transition from a dilute to a semi-dilute con-
centration regime, and thus occur at approximately the
same value. For the mAb data shown in Fig. 1, however,
there exists a large difference between the concentrations
related to the maxima in Mw,app and Rh,app, respectively.
This clearly indicates that a simple application of poly-
mer models, such as the wormlike chain model previously
used successfully to for example describe SLS and DLS
data for antigen-mAb complexes [32], does not work. We
thus instead exploit analogies to patchy colloids in or-
der to design a coarse-grained model for our system and
investigate whether we can obtain with this approach a
quantitative analysis of the experimental data.
COMPARING THEORY AND EXPERIMENTAL
RESULTS
Model: Antibodies as patchy particles
We model mAbs as patchy colloids and use a theoret-
ical approach that has previously been applied success-
fully to such particles, in order to calculate their struc-
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FIG. 1. Experimental results for the concentration de-
pendence of the mAb solutions. A) Apparent molecu-
lar weight Mw,app vs. weight concentration C as determined
by static light scattering. B) Apparent hydrodynamic radius
Rh,app vs. weight concentration C from dynamic light scat-
tering. C) Relative viscosity ηr vs. weight concentration C
measured by DLS-based microrheology.
tural properties as a function of concentration. Patchy
models are coarse-grained models which condense com-
plex anisotropic interactions often of electrostatic origin
in simple site-site aggregation, that have been applied
in the past to several protein solutions[33–39], and other
complex systems, including colloidal clays[40] and DNA-
based nanoconstructs[41, 42].
In order to build a meaningful model it is crucial to
identify the key ingredients controlling the intermolecu-
lar interactions. A previous study of this antibody has
shown that the viscosity is sensitive to the salt concentra-
tion, pointing towards electrostatic interactions as a main
component of the intermolecular interactions[5]. There-
fore, we first carry out a study of the electrostatic isosur-
face of a single antibody molecule in the considered buffer
solution, as described in Materials and Methods, in order
to locate the active spots on the molecule surface that
are involved in particle-particle aggregation. The result-
ing charge distribution is illustrated in Fig. 2A, which
clearly shows that the considered mAbs have an over-
all positively charged surface on the two arms (FAB do-
mains) and a largely negative charge on the tail (FC do-
main). This suggests that the main driving mechanism
for mAbs aggregation has to be an attractive arm-to-tail
interaction.
To take into account this result, we thus consider Y-
shaped particles formed by six spheres of diameter σ
and decorated with three patches, one of type A on the
tail and two of type B on the arms, as illustrated in
Fig. 2B. Interactions between AB patches are attractive
and modeled with a square-well potential, while AA and
BB interactions are not considered. To predict the be-
havior of our patchy model, which we call YAB model, we
use a thermodynamic perturbation theory, introduced by
Wertheim roughly 30 years ago, which describes associat-
ing molecules under the hypothesis that each sticky site
on a particle cannot bind simultaneously to two or more
sites on another particle [28]. The Helmholtz free energy
and the thermodynamic properties of the system, includ-
ing for example the energy per particle, the specific heat
at constant volume and the isothermal compressibility,
can thus be predicted from the dependence of the bond-
ing probability p on the temperature T and the num-
ber density ρ, as explained in more details in Materials
and Methods. We complement this approach with Monte
Carlo simulations of the YAB model in order to vali-
date the theoretical results. In addition, the YAB model
belongs to the class of hyperbranched polymers[29], for
which it is possible to calculate the equilibrium cluster
size distribution of the clusters solely from the knowledge
of the bonding probability p (see Materials and Methods).
As this parameter is directly an outcome of Wertheim
theory, the YAB model is amenable to a full analyti-
cal treatment, allowing one to obtain simultaneously the
thermodynamic and the connectivity properties of the
solutions, to be directly compared with the experimental
results.
Comparison between theory and MC simulations
The mAbs modeled as patchy Y-shaped colloids self-
associate into clusters with increasing concentration
through reversible AB bonds, as a result from the at-
traction between A and B patches. Their assembly can
be monitored by focusing on the variation of the bond-
ing probability p and the distribution n(s) of clusters of
size s as a function of the two parameters controlling the
assembly: the attractive strength kBT/, where  is the
well depth of the square-well attraction between A and
B patches (see Materials and Methods), T is the temper-
ature and kB is the Boltzmann constant, and the mAb
concentration C.
We report in Fig. 3 some representative results com-
paring theory and simulations, including the bond prob-
ability and the cluster size distributions for different con-
centrations and attraction strengths. In all cases, we find
that there is quantitative agreement between theory and
simulations for both thermodynamics and cluster observ-
ables. Thus, we can confidently use the results of the the-
oretical approach in order to compare with experimental
results.
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FIG. 2. Design of the patchy model of mAbs condensing electrostatic interactions into patch-patch specific
attraction. A: isosurfaces of the -1 (red) and +1 kBT (blue) electrostatic potential at pH 6.5 with 10 mM NaCl, indicating
an overall positive charge for the arms (FAB domains) and a largely negative charge for the tail (FC domain); B: illustration of
the patchy YAB model: 6 hard spheres (in green) each of diameter σ are constrained to a rigid Y shape, constituting a single
mAb molecule. Each molecule is decorated with one A patch on the tail (red) and two B (blue) patches, one on each arm,
respectively. Only AB attractive interactions are considered mimicking the arm-to-tail electrostatic interactions; C: schematic
view of the clustering process for mAb molecules forming hyperbranched structures.
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FIG. 3. Results from theory (lines) and simulations (symbols). A: Bond probability p as a function of mAb concentration
at different attraction strengths kBT/. Small deviations between theory and simulations only occur at high C; B: Cluster size
distributions n(s) for c = 25 mg/ml (left) and c = 150 mg/ml (right) for different kBT/; C: Cluster size distributions n(s) for
kBT/ = 0.0075 and several values of C; D: Simulation snapshots c = 25 mg/ml (left) and c = 150 mg/ml (right). Different
colours identify different cluster sizes.
5Structural Properties
In order to analyze the measured Mw,app, we calculate
the isothermal compressibility κT = −1/V (∂V/∂P )T for
our YAB model, since κT is related to the S(0), the static
structure factor at q = 0, as
S(0) = ρkBTκT , (1)
which in turn is related to the experimentally deter-
mined apparent weight average molar mass by Mw,app =
M1S(0) where M1 is the molar mass of a monomer. In a
solution where antibodies self-assemble into larger clus-
ters described via Wertheim theory, static light scatter-
ing thus provides an apparent weight average aggregation
number Napp given simply by
Napp = S(0), (2)
where Napp = Mw,app/M1 is the apparent aggregation
number, with M1 being the molar mass of a monomer.
When trying to understand self-assembly in mAb solu-
tions, we need to be able to account for both the average
aggregation number, Nagg, as well as the resulting in-
teraction effects between the antibody clusters, given by
S(0). Using Wertheim theory, we can calculate the free
energy and differentiate it twice in order to get κT . As de-
scribed in more details in Materials and Methods, the free
energy is the sum of a hard-sphere reference term plus a
bonding term. The reference HS term is the Carnahan-
Starling (CS) free energy of an equivalent HS system.
Since mAbs are not spherical, we cannot directly use the
actual volume fraction given by the number density of
mAbs and the volume of a monomer, but we rather need
to determine an equivalent hard sphere diameter σHS of
the Y-molecule. We thus calculate κT for different values
of σHS and kBT/ and compare it to the measured data.
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FIG. 4. Comparison of SLS data with patchy model
predictions. Experimental Napp compared with YAB model
results: the best agreement, particularly for high concentra-
tion data is obtained for an equivalent hard sphere diameter
σHS = 2.90σ ∼ 4.2nm and /kBT = 12.27.
By fitting the theoretical results to the experiments as
described in Materials and Methods, we determine the
two unknown parameters: the strength of the AB inter-
action and the equivalent HS diameter. Fig. 4 compares
Napp for the YAB model to the SLS data and we find that
the best fit of the data, particularly correctly describing
the high concentration behavior which is most relevant
for the viscosity to be discussed later, is obtained with
an effective hard sphere diameter of σHS = 2.9σ and
a strength of the AB patch-patch attraction given by
 ' 12.3kBT . Note that the estimated value of σHS is
considerably smaller than the geometric diameter of the
Y molecule, thus accounting for the penetrability of the
Y-shaped antibodies. When converted in real units, an
effective HS radius of 4.2 nm is found, which also com-
pares well with the measured radius of gyration of the
antibody molecule Rg ≈ 4.7 nm.
Dynamic Properties
Having analyzed the SLS data using Wertheim theory,
we now have a prediction for the effect of concentration
on the self-assembling behavior of mAbs and we can thus
calculate the cluster size distributions at all concentra-
tions thanks to HPT. Next we make an attempt to test
the consistency of these results with the data obtained
using DLS for the same samples shown in Fig. 1B. Unfor-
tunately, this is much less straightforward than the anal-
ysis of the SLS data and requires an additional coarse
graining step, illustrated in Fig. 5. The main problem
here is that we currently lack a theoretical model that
would allow us to calculate the effective or apparent hy-
drodynamic radius of concentrated solutions of polydis-
perse antibody clusters. We thus propose an approach
in which we use the self-assembled clusters of the patchy
model and treat them as new interacting objects. Their
dominant interaction is of course excluded-volume and,
hence, we consider them as effective polydisperse hard
spheres, each with its own radius resulting from its size
in terms of monomers. To go one more step, we also
consider them as sticky hard spheres.
Within this approach we first calculate the z-
average [43] hydrodynamic radius Rh,z of the mAb solu-
tions using the cluster size distributions obtained theoret-
ically. Next we model the solutions at each concentration
as dispersions of colloids with a size given by Rh,z and an
effective hard sphere volume fraction φHS . The influence
of interparticle interactions on the resulting collective dif-
fusion coefficient, or Rh,app, is calculated by treating the
spheres either as hard or sticky hard spheres, for which
accurate expressions exist.
First, we need to determine the hydrodynamic radius
Rh of mAb clusters of a given size Nagg. Clusters of
mAbs of a given size Nagg were generated randomly,
where the clusters also have to satisfy the criterion of
self-avoidance and where each monomer in a cluster is
allowed to have a maximum of 3 connections, i.e. reflect-
6FIG. 5. Schematic illustration of the coarse-graining strategy used to analyze the concentration-dependent cluster
formation and its effects on the structural and dynamic properties of the solution.
ing the YAB structure imposed in Wertheim theory and
HPT. For each individual cluster its hydrodynamic radius
was then calculated using the program Hydropro[44], and
average values were calculated from 100 individual clus-
ters. This resulted in a data set of Rh vs Nagg that
was well reproduced by the phenomenological relation-
ship Rh = 3.69 + 2.04×Nagg − 0.069×N2agg, where Rh
is given in nm.
With this relationship and assuming hard sphere-like
interactions between the different clusters, we can now
calculate the concentration dependence of both Napp and
Rh,app. The expression for the measured apparent molec-
ular mass in this coarse grained model is Mw,app =
MwS
eff (0), where Mw is the weight average molar mass
of the clusters. Note that the static structure factor Seff
introduced here has a different definition than S(0) intro-
duced in Eq. 1, and Seff = S(0)/Nagg now corresponds
to the effective structure factor of a solution of polydis-
perse spheres, reflecting the fact that the mAb clusters
and not the individual antibodies are the new interact-
ing objects. The apparent weight average aggregation
number Napp is then given by[43]
Napp = NaggS
eff (0). (3)
The only adjustable parameter introduced by this step
is the conversion of the weight concentration into the ef-
fective hard sphere volume fraction φHS of the clusters.
For hard spheres, we can exploit the Carnahan-Starling
expression for the low wavevector limit of the static struc-
ture factor,
SCS(0) =
(1− φHS)4
(1 + 2φHS)2 + φ3HS(φHS − 4)
, (4)
as well as the weight average aggregation number Nagg,
obtained with Wertheim theory and HPT, in order to
calculate Napp using Eq. 3. In doing these calculations
we fix the effective diameter σHS = 2.9σ of each antibody
molecule (Fig. 4).
The effective cluster HS volume fraction is calculated
taking into account that the excluded volume contribu-
tion of an antibody in a cluster is equal to a sphere with
a radius equal to the antibody radius of gyration and also
that clusters are fractal, giving
φHS =
(
2Rg
σHS
)3
φ N (3−dF )/dFagg = 1.41φ N
(3−dF )/dF
agg , (5)
where dF = 2.5 is the fractal dimension of the clus-
ters and φ is the nominal antibody volume fraction
(φ = pi/6ρd3) based on the geometric diameter d of the
molecule. Thus, in the coarse grained model we have
an effective hard sphere volume fraction that is ≈ 40%
higher than for the individual mAbs in the Wertheim
analysis, which does not seem unrealistic because clus-
ters cannot overlap as much as individual antibodies do.
The resulting comparison of the model calculations with
experiments provides a very good description of the data,
as shown in Fig. 6 A.
In order to calculate Rh,app we use the corresponding
virial expression for the short time collective diffusion
coefficient, which results in
Rh,app = Rh/(1 + kDφHS), (6)
where kD = 1.45 for hard spheres [45]. Note that here we
use the z-average aggregation number in order to calcu-
late Rh. The agreement for Rh,app with the results from
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FIG. 6. Comparison between experimental and the-
oretical results for the concentration dependence of
static and dynamic properties of the mAb solutions.
Blue symbols are experimental data, while solid lines are the
theoretical data for the hard sphere (orange line) and the
sticky hard sphere (green line) models, respectively. The fit
parameters are reported in TableI. A: Apparent aggregation
number Napp versus weight concentration as determined by
SLS; B: Apparent hydrodynamic radius Rh,app versus weight
concentration from dynamic light scattering; C: Reduced vis-
cosity ηr versus weight concentration measured by DLS-based
microrheology.
the simple hard sphere model is quite good (Fig. 6B), ex-
cept for the highest values of C, where we expect Eq. 6
to fail and would instead need to include higher order
terms. We also find that the apparent hydrodynamic
radius obtained in DLS experiments is very sensitive to
the interparticle interactions, and we can thus also look
at a somewhat refined interaction model, where we also
include the possibility of an additional weak attraction
between different clusters. Here we use the so-called ad-
hesive or sticky hard sphere model [46, 47], where we
include an additional weak short-range attractive poten-
tial that could be due to the unbound attractive patches
of the mAbs at the exterior of the clusters. In this model,
Eqs. 4 and 6 then become
SSHS(0) =
(1− φHS)4
(1 + 2φHS − λφHS)2 , (7)
and
Rh,app = Rh/(1 + (1.45− 1.125/τ)φHS), (8)
where τ is the stickiness parameter that is inversely pro-
portional to the strength of the attractive interaction and
λ is given by
λ = 6(1− τ + τ/φ)
(
1−
√
1− 1 + 2/φ
6(1− τ + τ/φ)2
)
. (9)
The corresponding theoretical curves when τ is used as
an additional fit parameter to the SLS and DLS data
are also shown in Fig. 6A and B. In particular, a better
description of the apparent hydrodynamic radius is ob-
tained within the SHS model with τ ∼ 2.5, corresponding
to a very weak additional attraction between the mAb
clusters. While the approximations made in our coarse
grained strategy may be too severe to say much about the
exact nature of the effective interaction potential between
the mAb clusters in solution, the experimental data are
very well reproduced by our simple model. This indi-
cates that the two chosen models, a pure hard sphere
and an adhesive hard sphere interaction with moderate
stickiness, likely bracket the true behavior of the self-
assembling antibody investigated in this study.
Finally, as an ultimate test, we calculate the concen-
tration dependence of the relative viscosity ηr. We use
the expression for ηr developed by Mooney, which is of-
ten and successfully applied for mono- and polydisperse
hard sphere colloidal suspensions [48]:
ηr = e
AφHS
(1−φHS/φg) . (10)
Here A is a constant, which for hard spheres is 2.5, and φg
is the maximum packing fraction, which depends on the
polydispersity of the system. In order to estimate it, we
have evaluated the polydispersity of our antibody clus-
ters as a function of concentration and find that at the
highest studied concentration it reaches about 45%. For
such polydisperse hard spheres, the maximum packing
fraction is ≈ 0.71[49]. Using this value, we then should
directly obtain the concentration dependence of ηr from
the previously determined relationship between C and
φHS without any free parameter. The resulting compar-
ison between the measured and calculated values of ηr
is shown in the bottom panel of Fig. 6, and the agree-
ment is indeed quite remarkable given the lack of any
free parameter. This clearly indicates that it is the ex-
cluded volume interactions between the self-associating
clusters that is at the origin of the strong increase of the
zero shear viscosity with increasing concentration, and
our simple model is capable of predicting the measured
C-dependence based on static and dynamic light scatter-
ing experiments quantitatively.
DISCUSSION AND CONCLUSIONS
The self-assembly of monoclonal antibodies and its ef-
fect on the solution properties such as the viscosity is
an important factor in determining our ability to de-
velop high concentration formulations. However, there
8has been a lack of decisive experimental and theoreti-
cal approaches to obtain a quantitative and predictive
understanding of antibody solutions. A recent theoret-
ical study has proposed a patchy model for antibody
molecules[50], in which different types of patch-patch at-
tractions were considered resulting in a large number of
parameters to be adjusted to describe different experi-
mental conditions. On the other hand, in the present
work we define the simplest model based on electrostatic
calculations for the specific type of immunoglobulin also
studied experimentally within the same buffer and salt
conditions. This very simple model is analytically solv-
able by well-established theories, in particular the combi-
nation of the Wertheim theory with hyperbranched poly-
mer theory to predict the aggregation properties of the
mAb solutions. We have also shown that both thermo-
dynamic properties and cluster distributions are in quan-
titative agreement with MC simulations of the model,
thus the theoretical predictions can be directly compared
with experiments without suffering from numerical un-
certainty. From the mAb self-assembly process built by
the patchy interactions, we then employ a second coarse-
graining step in which we consider our antibody clusters
as the elementary units. We thus use the most basic de-
scription considering these clusters interacting essentially
as hard spheres or sticky hard spheres with very moder-
ate attraction, and apply available phenomenological de-
scriptions to predict the dynamic properties of the sys-
tem. This treatment does essentially not depend on any
free parameter and is able to reproduce all measured data
from SLS, DLS and microrheology. This simple model,
based on very fundamental assumptions, thus provides an
elegant way to consistently describe the thermodynamic
and dynamical behavior of mAb solutions.
The patchy model that we have established also pro-
vides a robust estimate of the attraction between patchy
binding sites through Wertheim theory, and thus will be
an ideal starting point to investigate and quantitatively
assess the effects of additional excipients or chemical
modifications on the antibody interaction. Such informa-
tion is vital for an advanced formulation strategy and at-
tempts to predict antibody stability and the resulting vis-
cosity from molecular information. Moreover, the com-
bination of static scattering data and Wertheim/HPT to
determine the interaction strength and the cluster size
distribution as a function of concentration, and the subse-
quent test using DLS and (micro)rheology measurements
without additional free parameters other than a rescal-
ing of the volume fraction, allows us to critically test
models for the type of interactions responsible for the
self-association of a given mAb into clusters.
I. MATERIALS AND METHODS
Sample preparation
The mAb used in this study was a humanized IgG4
against trinitrophenyl , which was previously found to
exhibit an increased viscosity at high concentrations [5]
(where it was labeled mab-C ). It was manufactured
by Novo Nordisk A/S and purified using Protein A
chromatography, and subsequently concentrated to 100
mg/ml and buffer exchanged into a 10 mM Histidine
buffer with 10 mM NaCl at pH 6.5.
For measurements, the sample was diluted and buffer
exchanged to a 20mM Histidine pH 6.5 buffer contain-
ing 10 mM NaCl and subsequently concentrated using a
100 kD cutoff spinfilter (Amicon inc.). The concentrated
sample was used as a stock solution for preparing the
less concentrated ones. The concentration of each sam-
ple was determined by a series of dilutions followed by
measurement of the absorption at 280nm using an ex-
tinction coefficient of e280nm1%,1cm = 2.234. In order to assess
the uncertainty of the concentration determination the
dilution series was done in triplicates.
Light Scattering
The dynamic and static light scattering experiments
were made using a 3D-LS Spectrometer (LS Instruments
AG, Switzerland) with a 632nm laser, recording DLS
and SLS data simultaneously. The measurements were
conducted at 90◦ scattering angle. Before measurement,
the samples were transferred to pre-cleaned 5mm NMR
tubes and centrifuged at 3000 g and 25 ◦C for 15 min,
to remove any large particles and to equilibrate temper-
ature. Directly after centrifugation, the samples were
placed in the temperature equilibrated sample vat and
the measurement was started after 5 minutes to allow
for thermal equilibration. Additional low concentration
SLS measurements were done using a HELIOS DAWN
multi-angle light scattering instrument (Wyatt Technol-
ogy Corporation, CA, USA), connected to a concentra-
tion gradient pump. Both instruments were calibrated to
absolute scale using a secondary standard, allowing for
direct comparison of the two data sets.
Microrheology
The zero shear viscosity η0 was obtained using DLS-
based tracer microrheology. Sterically stabilized (pe-
gylated) latex particles were mixed with protein sam-
ples to a concentration of 0.01 %v/v using vortexing
and transferred to 5 mm NMR tubes. The sterically
stabilized particles were prepared by cross-linking 0.75
kDa amine-PEG (poly-ethylene glycol) (Rapp Polymere,
12750-2) to carboxylate stabilized polystyrene (PS) parti-
9cles (ThermoFischer Scientific, C37483) with a diameter
of 1.0 µm using EDC (N-(3-Dimethylaminopropyl)-N’-
ethylcarbodiimide) (Sigma Aldrich, 39391) as described
in detail in [51]. DLS measurements were performed on a
3D-LS Spectrometer (LS Instruments AG, Switzerland)
at a scattering angle of 46-50◦ to stay away from the par-
ticle form factor minima and thus to maximise the scat-
tering contribution from the tracer particles with respect
to the protein scattering. Measurements were made us-
ing modulated 3D cross correlation DLS [52] to suppress
all contributions from multiple scattering that occur in
the attempt to achieve conditions where the total scat-
tering intensity is dominated by the contribution from
the tracer particles. Samples were either prepared indi-
vidually or diluted from more concentrated samples us-
ing a particle dispersion with the same particle concen-
tration as in the sample as the diluent. The diffusion
coefficient D of the particles was then extracted from
the intensity autocorrelation function using a 1st order
cumulant analysis of the relevant decay. This diffusion
coefficient is compared to that of particles in a protein-
free buffer and the relative viscosity is extracted from the
relationship between diffusion coefficient and viscosity in
the Stokes-Einstein equation given by D = kBT/6piη0Rh,
where Rh is the known hydrodynamic radius of the tracer
particles[51, 53].
Isosurface calculations
The FAB domains were built using the antibody
modeler tool in the Molecular Operating Environment
(Chemical Computing Group Inc, Canada) computer
program[54], whereas the FC domain was taken from
a crystallographic structure with a similar FC domain
found in the protein data bank (PDBID: 4B53) The elec-
trostatic calculations were done in a two step process, us-
ing pdb2prq [55] and the automated poisson Boltzmann
solver[56] (apbs) pymol plugin. The pdb2pqr server is
hosted by the National Biomedical Computation Re-
source at http://nbcr-222.ucsd.edu/pdb2pqr 2.1.1/, and
was used to calculate the protonation state of the FAB
and FC domains at pH 6.5 taking the local structure
around the titratable residues into account. The pre-
pared structures were then used by the apbs plugin to
calculate an electrostatic map of the protein. The apbs
was run using the default parameters, with the addition
of Na+ and Cl- ions corresponding to a salt concentration
of 10mM.
YAB Patchy model and MC simulations
The antibody molecule is represented as a symmetric
Y -shaped particle, constructed from six hard spheres of
diameter σ, as illustrated in Fig. 2B. Each mAb is deco-
rated by 3 patches, one of type A on the tail and two of
type B on the arms. Only AB interactions are taken into
account based on the charge distribution on the surface
of the mAb molecule in the studied buffer conditions, and
are modeled as an attractive square well (SW) potential
of range δ = 0.1197σ, which guarantees that each patch
is engaged at most in one bond. For this model the ge-
ometric diameter d of a single mAb molecule is that of
the circle tangent to the external spheres: d = 9+2
√
3
3 σ.
We perform standard MC simulations of N = 1000
YAB particles at different number densities ρ = N/V
where V is the volume of the cubic simulation box. The
unit of length is σ. To compare the experimental value of
C with simulations and theory, we consider the geometric
radius d/2 of the Y-colloid equal to the hydrodynamic
radius measured for a single mAb molecule, that is ≈
6nm. With this choice we have that σ ≈ 2.89nm and,
considering that the mass of a molecule is 150 kDa, an
experimental concentration of 1 mg/ml corresponds to
9.6938× 10−5/σ3 in simulation units.
Theory
In Wertheim theory[28, 57], the free energy F of a sys-
tem of N particles in a volume V , with number density
ρ = N/V , is calculated as the sum of a hard sphere refer-
ence term plus a bonding term. The bonding free energy
Fb per particle of the YAB model is
β
Fb
N
= 2 lnXB + lnXA −XB − XA
2
+
3
2
(11)
where XA and XB are the fractions of non-bonded patch
of each species respectively[58] and β = 1kBT . For the
Y AB model they are:
XA =
1
1 + 2ρ∆XB
; XB =
1
1 + ρ∆XA
, (12)
with ∆ = vB [e
β0 − 1] 1−Aη−Bη2(1−η)3 , vB = piδ4 15σ+4δ30σ2 , A =
5
2
3+8δ/σ+3(δ/σ)2
15+4δ/σ , B =
3
2
12δ/σ+5(δ/σ)2
15+4δ/σ , η =
pi
6 ρσ
3[59, 60].
The reference HS system must be chosen according to
the nature of the molecule. For non-spherical molecules,
the HS reference system effective diameter is not known
and needs to take into account correctly the excluded vol-
ume of the particles. This is established from the compar-
ison to experiments. Once this is known, experimentally
accessible quantities such as the osmotic compressibility
of the system can be directly calculated from the expres-
sion of F . From Eq. 12 we can calculate the expressions
for the fractions of non bonded patches in terms of den-
sity and temperature, as
XA =
2
1 + ρ∆ +
√
ρ2∆2 + 6ρ∆ + 1
;
XB =
ρ∆− 1 +
√
ρ2∆2 + 6ρ∆ + 1
4ρ∆
. (13)
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Instead of using these two variables, it is more convenient
to refer to the so-called bond probability p, defined as
p ≡ pB = 1−XB = pA
2
=
1−XA
2
. (14)
While Wertheim theory directly provides overall quan-
tities such as the compressibility or the fraction of bonded
A and B groups as a function of p, it does not yield the
resulting cluster size distribution that would be needed
for a comparison with other experimental quantities. We
thus apply hyperbranched polymer theory (HPT) ex-
ploiting the fact that the YAB molecule is of the kind
ABf−1 in HPT language with f = 3[29]. We consider p
to be the fraction of bondedB groups (i.e. the bond prob-
ability of Wertheim theory defined above) and (f − 1)p
the fraction of bonded A groups. There is one non-
bonded A group for each cluster, therefore the average
number of monomers per cluster is the reciprocal of the
fraction of unreacted A groups. The only input then
needed to evaluate the cluster size distribution n(s) is the
bond probability p, which we get from Wertheim theory.
In the YAB model, calling p (2p) the fraction of B (A)
patchy sites, the cluster size distribution in the frame-
work of hyperbranched polymer theory is finally given
by
n(s) =
(2s)!
s!(s+ 1)!
ps−1(1− p)s+1, (15)
where n(s) is the probability of finding clusters of size s
for a system with bond probability p. From the cluster
size distributions calculated we then calculate the weight
average, the z-average and the polydispersity of the clus-
ters for each concentration.
Finally in order to evaluate S(0) as a function of con-
centration, we simply perform a double derivative of the
free energy in order to get the compressibility of the
system[61].
Model fitting
All data are fitted using the orthogonal distance regres-
sion procedure[62, 63], which includes the experimental
errors in both the x and y directions. The full set of
fit parameters are given in table I. For the hard sphere
model fits shown in Fig. 6 two parameters are fitted: The
bonding energy and a scaling factor of the SLS data. The
scaling factor is introduced to correct for any errors in
the calibration linking the scattering intensity to the ap-
parent molecular mass, and should be close to one. For
the sticky hard sphere model three parameters are fit-
ted: The bonding energy, the stickiness parameter and
a scaling factor for the SLS data. For the fits using the
compressibility from Wertheim theory (figure 4), the first
fit uses three free parameters, the bonding energy, a scal-
ing factor of the SLS data and an effective hard sphere
scaling factor. In the second fit the effective hard sphere
scaling factor is locked to σHS and only the bonding en-
ergy and scaling factor are fitted.
Model fit /kBT σHS/σ τ SLS scale
Compressibility
full fit
12.04± 0.042.70± 0.03 -0.994± 0.002
Compressibility12.27± 0.03 2.9∗ -0.984± 0.003
HS Model 12.33± 0.03 2.9∗ -0.992± 0.008
Sticky HS Model12.24± 0.03 2.9∗2.45± 0.450.993± 0.006
TABLE I. Table of the obtained fit parameters. The ∗
indicates a fixed parameter.
Generation of Antibody Clusters
The antibody clusters were generated using a molecu-
lar model of the antibody, from low concentration SAXS
data [Article in preparation] constructed using the SAXS
modeling software BUNCH[64]. The FC and FAB do-
mains (generated as described in the isosurface calcu-
lations section) were represented as rigid bodies, linked
together with a flexible linker of dummy residues. The
linker was further constrained by linking the dummy
residues that represent the cysteine residues together to
simulate the cysteine bridges in the hinge region of an
IgG4.
To generate a self-associated antibody cluster contain-
ing N antibodies, the following procedure was used:
1. An initial antibody was placed with its center of
mass (CM) at the origin and oriented randomly.
2. A new antibody is placed at a distance of 12.5 nm in
a random direction from the initial antibody CM,
and oriented randomly and a connection between
them is recoded.
3. From the already placed antibodies one is selected
at random if it has less that 3 connections.
4. A new antibody is now placed distance of 12.5 nm
in random direction from the selected antibody, ori-
ented randomly. The distance between the CM of
the newly placed antibody and all other placed an-
tibodies is calculated, and if it is 12.5 nm or more
the connection is recorded. If not step 4 is repeated.
5. Steps 3 and 4 are repeated until N antibodies have
been placed.
For each association number, N, 100 clusters were pro-
duced using the method above.
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